"49401-101-01" National Drug Code (NDC)

Benlysta 1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL
(GlaxoSmithKline LLC)

NDC Code49401-101-01
Package Description1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL
Product NDC49401-101
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameBenlysta
Non-Proprietary NameBelimumab
Dosage FormINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
UsageINTRAVENOUS
Start Marketing Date20110310
Marketing Category NameBLA
Application NumberBLA125370
ManufacturerGlaxoSmithKline LLC
Substance NameBELIMUMAB
Strength120
Strength Unitmg/1.5mL
Pharmacy ClassesB Lymphocyte Stimulator-directed Antibody Interactions [MoA], B Lymphocyte Stimulator-specific Inhibitor [EPC], Decreased B Lymphocyte Activation [PE]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/49401-101-01